Heteroaryloxycarbocyclyl Compounds as PDE 10 Inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160280703A1
SERIAL NO

14579733

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Heteroaryloxycarbocyclyl compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, Huntington's Disease, bipolar disorder, obsessive-compulsive disorder, and the like.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMGEN INCONE AMGEN CENTER DRIVE LAW DEPARTMENT THOUSAND OAKS CA 91320-1799

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allen, Jennifer R Newbury Park, US 57 505
Frohn, Michael J Thousand Oaks, US 46 387
Harrington, Essa Hu Camarillo, US 12 40
Harrington, Paul E Camarillo, US 23 202
Pickrell, Alexander J Westlake Village, US 38 337

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation